Literature DB >> 19184608

Comment on Shuhaibar et al.: Favourable effect of immunomodulator therapy on bone mineral density in multiple sclerosis.

M T Kampman, L H Steffensen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19184608     DOI： 10.1007/s11845-009-0275-y

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN： 0021-1265            Impact factor:   1.568


× No keyword cloud information.
  1 in total

1.  Favorable effect of immunomodulator therapy on bone mineral density in multiple sclerosis.

Authors:  M Shuhaibar; M J McKenna; M Au-Yeong; J M T Redmond
Journal:  Ir J Med Sci       Date:  2008-11-12       Impact factor: 1.568
  1 in total
  4 in total

1.  Immunomodulators for multiple sclerosis may ameliorate spinal bone loss.

Authors:  M J McKenna; B Murray; R Lonergan; J M T Redmond
Journal:  Ir J Med Sci       Date:  2012-04-07       Impact factor: 1.568

2.  Predictors and prevalence of low bone mineral density in fully ambulatory persons with multiple sclerosis.

Authors:  Linn Hofsøy Steffensen; Svein Ivar Mellgren; Margitta T Kampman
Journal:  J Neurol       Date:  2009-10-01       Impact factor: 4.849

3.  Assessment of bone densitometry in Iranian patients with multiple sclerosis: A case-control study.

Authors:  Mehdi Moghaddasi; Mahbubeh Aghaei
Journal:  Iran J Neurol       Date:  2013

4.  High dose vitamin D supplementation does not affect biochemical bone markers in multiple sclerosis - a randomized controlled trial.

Authors:  Trygve Holmøy; Jonas Christoffer Lindstrøm; Erik Fink Eriksen; Linn Hofsøy Steffensen; Margitta T Kampman
Journal:  BMC Neurol       Date:  2017-04-04       Impact factor: 2.474
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.